Advertisement
Screener

Enovis Corp (ENOV) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

Enovis Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

Enovis Corp (ENOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-02-26

  • Enovis Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.00.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $26.36, a 4.08% decline from fiscal 2022.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $27.48, a 0.58% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-02-26
2024-12-31$0.00
10-K · filed 2026-02-26
2023-12-31$26.36
10-K · filed 2026-02-26
2022-12-31$27.48
10-K · filed 2025-02-26
2021-12-31$27.64
10-K · filed 2024-02-22
$16.25
10-K · filed 2022-02-22
2020-12-31$20.22
10-K · filed 2023-03-01
$11.81
10-K · filed 2021-02-18
2019-12-31$8.80
10-K · filed 2022-02-22
2018-12-31$10.37
10-K · filed 2021-02-18
2017-12-31$12.16
10-K · filed 2020-02-24
2016-12-31$9.47
10-K · filed 2019-02-21
2015-12-31$11.87
10-K · filed 2018-02-16
2014-12-31$22.65
10-K · filed 2017-02-14
2013-12-31$18.07
10-K · filed 2016-02-16
2012-12-31$13.14
10-K · filed 2015-02-17
2012-09-28$12.94
10-Q · filed 2012-10-31
2012-06-29$12.97
10-Q · filed 2012-08-07
2011-12-31$9.68
10-K · filed 2014-02-12
2010-12-31$5.63
10-K · filed 2013-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85